Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Exogene is a techbio startup leveraging deep learning to discover innovative TCR-based therapies for cancer treatment. By harnessing the natural ability of human T-cells to eliminate diseased cells,…

Exogene is a techbio startup leveraging deep learning to discover innovative TCR-based therapies for cancer treatment. By harnessing the natural ability of human T-cells to eliminate diseased cells,…
What they do: AI-enabled discovery and engineering of T-cell receptors (TCRs) for cancer therapies
Founded: 2019
Headquarters: Oxford, United Kingdom
Notable funding: $2.0M seed (Apr 2022)
Team size (approx.): 14 employees
TCR discovery and engineering for cancer immunotherapies (solid tumours)
2019
Biotechnology
2,000,000 USD
Seed round to develop AI-enabled TCR discovery platform; participating investors included R42 Group, Jude Gomila, Nadav Rosenberg, Stefano Bernardi, KQ Labs, Entrepreneur First, Sigmas Group and other angels.
“Participated by specialist VC and angel investors focused on deep tech and biotech”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week